Kelly Bliss - Oct 1, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, U.S. Group Health
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Oct 1, 2024
Transactions value $
-$7,783
Form type
4
Date filed
10/2/2024, 04:13 PM
Previous filing
Sep 27, 2024
Next filing
Dec 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2.63K +9.94% 29.1K Oct 1, 2024 Direct F1
transaction TDOC Common Stock Sale -$7.78K -897 -3.08% $8.68 28.2K Oct 2, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -2.63K -100% $0.00 0 Oct 1, 2024 Common Stock 2.63K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.